Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Chitosan styptic powder and preparation method thereof

A technology of chitosan and hemostatic powder, which is applied in the field of biomedical materials, can solve the problems of poor process stability, uncertain lactic acid content, large amount of ethanol, etc., and achieves the effects of simple preparation process, reduced production cost, and small amount of ethanol.

Active Publication Date: 2020-09-29
SHIJIAZHUANG YISHENGTANG MEDICAL SUPPLIES
View PDF7 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] Domestic research on chitosan hemostatic powder is relatively late, and the hemostatic effect of prepared chitosan hemostatic powder is poor, and it cannot effectively stop bleeding from large arteries, and the amount of ethanol used in the preparation process is large, and the production cost is high
[0005] The publication number is CN106810624A, which discloses a preparation method of chitosan lactate. Chitosan and lactic acid ethanol solution react under stirring conditions. After the reaction, continue to use the lactic acid ethanol system by adding lactic acid. There is ethanol in the process. The consumption is large, the cost is high, the lactic acid ethanol system that continues to be used is impure, the lactic acid content is uncertain, and the process stability is poor

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0029] Adopt following method to prepare chitosan hemostatic powder:

[0030] (1) Weigh 100g of chitin, add it to 3000ml of 40% alkaline solution, and carry out deacetylation reaction at 50°C, and the reaction time is 5h;

[0031] (2) After the reaction, filter and wash the filter cake with purified water until neutral;

[0032] (3) blast drying to obtain chitosan weighing 76g;

[0033] (4) Add the chitosan prepared in the above steps to 700ml of ethanol solution containing 1% lactic acid and 0.12% lactic anhydride, and react for 2h under rotating conditions;

[0034] (5) After the reaction, rotate and vacuum dry at 40°C for 1 hour to obtain chitosan hemostatic powder. After testing, the lactic anhydride content was 1.27%.

Embodiment 2

[0036] Adopt following method to prepare chitosan hemostatic powder:

[0037] (1) Weigh 100g of chitin, add it to 2500ml of 55% alkaline solution, and carry out deacetylation reaction at 85°C, and the reaction time is 0.5h;

[0038] (2) After the reaction, filter and wash the filter cake with purified water until neutral;

[0039] (3) Blast drying to obtain chitosan weighing 73g;

[0040] (4) Add the chitosan prepared in the above steps to 600ml ethanol solution containing 2% lactic acid and 0.35% lactic anhydride, and react for 2h under rotating conditions;

[0041] (5) After the reaction, rotate and vacuum dry at 30° C. for 1.5 h to obtain chitosan hemostatic powder. After testing, the lactic anhydride content was 3.16%.

Embodiment 3

[0043] Adopt following method to prepare chitosan hemostatic powder:

[0044] (1) Weigh 100g of chitin, add it to 2200ml of alkaline solution with a concentration of 65%, and carry out deacetylation reaction at 70°C, and the reaction time is 2.5h;

[0045] (2) After the reaction, filter and wash the filter cake with purified water until neutral;

[0046] (3) blast drying to obtain chitosan weighing 74g;

[0047] (4) Add the chitosan prepared in the above steps to 620ml ethanol solution containing 3% lactic acid and 0.55% lactic anhydride, and react under rotation for 10min;

[0048] (5) After the reaction, spin vacuum drying at 55° C. for 0.5 h to obtain chitosan hemostatic powder. After testing, the content of lactic anhydride was 5.92%.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides chitosan styptic powder and a preparation method thereof. A main component of the chitosan styptic powder is chitosan lactate, the chitosan styptic powder contains 1%-8% of lactic anhydride and can realize effective hemostasis of arteria cruralis within 3 min; and a preparation process is simple, yield of products is high, ethanol can be recycled, and production cost is greatly reduced.

Description

technical field [0001] The invention belongs to the field of biomedical materials, and in particular relates to a chitosan hemostatic powder and a preparation method thereof. Background technique [0002] Uncontrolled hemorrhage is the main cause of death on the battlefield. First aid for wounded soldiers as early as possible and control of hemorrhage become the best strategy to reduce the death of soldiers. [0003] Chitosan is a natural polymer biomaterial, a positively charged polysaccharide that can absorb negatively charged blood cells and promote blood coagulation. Chitosan's properties of hemostasis, biocompatibility, microbial degradability, and easy gel formation endow it with good performance as a hemostatic material. [0004] Domestic research on chitosan hemostatic powder is relatively late, and the prepared chitosan hemostatic powder has poor hemostatic effect and cannot effectively stop bleeding from large arteries, and the amount of ethanol used in the prepar...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61L24/08C08B37/08
CPCA61L24/08C08B37/003A61L2400/04C08L5/08
Inventor 李素哲黄栋刘俊英于蕊孙丙辉张志宝张丽红史思饶
Owner SHIJIAZHUANG YISHENGTANG MEDICAL SUPPLIES
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com